|
Market Closed -
Nasdaq
04:00:00 03/10/2026 HKT
|
After hours 08:00:00 | |||
| 190.01 USD | +0.57% |
|
188.00 | -1.06% |
| 10-02 | Nasdaq hits record high after softer jobs data tempers rate-hike bets | RE |
| 10-02 | Weak Jobs Lead to Stronger Stocks |  |
| Market Cap | 75.86B 67.4B 62.91B 57.34B 108B 7,293B 109B 761B 295B 3,728B 285B 279B 11,965B | P/E 2026 * |
-22.7x | P/E 2027 * | -39.7x |
|---|---|---|---|---|---|
| Enterprise Value | 72.21B 64.15B 59.88B 54.58B 103B 6,941B 104B 725B 281B 3,549B 271B 265B 11,388B | EV / Sales 2026 * |
34.4x | EV / Sales 2027 * | 30.3x |
| Free-Float |
92.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MRNA | Delayed | |
CBOE
| MRNA | Real-time | |
|
Tradegate
| 0QF | Real-time | |
|
Xetra
| 0QF | Delayed | |
|
Borsa Italiana
| 1MRNA | End-of-day quote | |
|
Boerse Muenchen
| 0QF | Real-time | |
|
CBOE
| Real-time | ||
|
CBOE
| 0A45 | Real-time | |
|
Mexican S.E.
| MRNA * | End-of-day quote | |
|
Börse Stuttgart
| 0QF | Delayed | |
|
London S.E.
| 0A45 | Delayed | |
|
Deutsche Boerse AG
| 0QF | Delayed | |
|
Kazakhstan S.E.
| MRNA_KZ | End-of-day quote | |
|
Wiener Boerse
| MRNA | End-of-day quote | |
|
Lima
| MRNAUS | End-of-day quote | |
|
Swiss Exchange
| MRNA | Delayed | |
|
Swiss Exchange
| MRNA | Delayed |
Last Transcript: Moderna, Inc.
| 1 day | -1.06% | ||
| 1 week | -4.46% | ||
| Current month | -1.33% | ||
| 1 month | +25.99% | ||
| 3 months | +138.23% | ||
| 6 months | +286.20% | ||
| Current year | +544.32% |
| 1 week | 183.28 |  | 208.9 |
| 1 month | 130.38 | | 208.9 |
| Current year | 29.81 | | 208.9 |
| 1 year | 22.28 | | 208.9 |
| 3 years | 22.28 | | 208.9 |
| 5 years | 22.28 | | 376.65 |
| 10 years | 11.54 | | 497.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 54 | 01/03/2011 |
James Mock
DFI | Director of Finance/CFO | 49 | 06/09/2022 |
Stephen Hoge
PSD | President | 50 | 01/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Noubar Afeyan
CHM | Chairman | 63 | 01/02/2012 |
Stéphane Bancel
BRD | Director/Board Member | 54 | 01/03/2011 |
Francois Nader
BRD | Director/Board Member | 69 | 11/12/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/9/26 | Exercice | Chairperson | 193,185 | 0.0484% | ||
| 10/9/26 | Exercice | Chief Financial Officer | 74,508 | 0.0187% | ||
| 4/9/26 | Exercice | General Counsel | 29,298 | 0.0073% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.57% | -4.46% | +569.76% | +83.92% | 75.86B | |
| -0.61% | -3.43% | +39.40% | +112.31% | 1,019B | |
| -1.02% | -5.60% | +37.67% | +65.02% | 617B | |
| +1.11% | -0.58% | +11.10% | +77.28% | 464B | |
| +0.34% | -3.01% | +61.21% | +40.71% | 356B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 333B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 267B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 244B | |
| -1.04% | -2.79% | +35.52% | +51.34% | 218B | |
| -1.87% | -4.10% | +30.92% | +95.33% | 179B | |
| Average | -0.32% | -3.50% | +81.43% | +59.83% | 377.3B | |
| Weighted average by Cap. | +0.39% | -3.35% | +41.36% | +69.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.1B 1.87B 1.74B 1.59B 3B 202B 3.02B 21.09B 8.17B 103B 7.89B 7.72B 331B | 2.43B 2.16B 2.02B 1.84B 3.47B 234B 3.5B 24.43B 9.47B 120B 9.14B 8.94B 384B |
| Net income | -3.31B -2.94B -2.75B -2.5B -4.72B -318B -4.76B -33.23B -12.88B -163B -12.43B -12.16B -522B | -1.95B -1.73B -1.61B -1.47B -2.77B -187B -2.8B -19.54B -7.57B -95.66B -7.31B -7.15B -307B |
| Net Debt | -3.65B -3.25B -3.03B -2.76B -5.21B -351B -5.26B -36.66B -14.21B -180B -13.71B -13.42B -576B | -2.17B -1.93B -1.8B -1.64B -3.09B -209B -3.12B -21.78B -8.44B -107B -8.15B -7.97B -342B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | US$190.01 | +0.57% | 10,289,461 |
| 01/10/26 | US$188.94 | -1.89% | 15,437,001 |
| 30/09/26 | US$192.57 | -5.35% | 20,649,483 |
| 29/09/26 | US$203.46 | +3.13% | 13,277,922 |
| 28/09/26 | US$197.28 | -0.80% | 13,359,640 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRNA Stock
Select your edition
All financial news and data tailored to specific country editions
